Artykuły w czasopismach na temat „Clot structure”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Sprawdź 50 najlepszych artykułów w czasopismach naukowych na temat „Clot structure”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Przeglądaj artykuły w czasopismach z różnych dziedzin i twórz odpowiednie bibliografie.
Smith, Stephanie A., i James H. Morrissey. "Polyphosphate Enhances Fibrin Clot Structure." Blood 110, nr 11 (16.11.2007): 403. http://dx.doi.org/10.1182/blood.v110.11.403.403.
Pełny tekst źródłaMihalko, Emily, i Ashley C. Brown. "Clot Structure and Implications for Bleeding and Thrombosis". Seminars in Thrombosis and Hemostasis 46, nr 01 (15.10.2019): 096–104. http://dx.doi.org/10.1055/s-0039-1696944.
Pełny tekst źródłaWolberg, Alisa S., Dougald M. Monroe, Harold R. Roberts i Maureane Hoffman. "Elevated prothrombin results in clots with an altered fiber structure: a possible mechanism of the increased thrombotic risk". Blood 101, nr 8 (15.04.2003): 3008–13. http://dx.doi.org/10.1182/blood-2002-08-2527.
Pełny tekst źródłaSmith, Stephanie A., i James H. Morrissey. "Polyphosphate enhances fibrin clot structure". Blood 112, nr 7 (1.10.2008): 2810–16. http://dx.doi.org/10.1182/blood-2008-03-145755.
Pełny tekst źródłaCelińska-Löwenhoff, Magdalena, Teresa Iwaniec, Agnieszka Padjas, Jacek Musiał i Anetta Undas. "Altered fibrin clot structure/function in patients with antiphospholipid syndrome: association with thrombotic manifestation". Thrombosis and Haemostasis 112, nr 08 (2014): 287–96. http://dx.doi.org/10.1160/th13-11-0980.
Pełny tekst źródłaCarr, M. E., i S. L. Zekert. "Abnormal clot retraction, altered fibrin structure, and normal platelet function in multiple myeloma". American Journal of Physiology-Heart and Circulatory Physiology 266, nr 3 (1.03.1994): H1195—H1201. http://dx.doi.org/10.1152/ajpheart.1994.266.3.h1195.
Pełny tekst źródłaGersh, Kathryn, Chandrasekaran Nagaswami i John Weisel. "Fibrin network structure and clot mechanical properties are altered by incorporation of erythrocytes". Thrombosis and Haemostasis 102, nr 12 (2009): 1169–75. http://dx.doi.org/10.1160/th09-03-0199.
Pełny tekst źródłaHenderson, Sara J., Jing Xia, Huayin Wu, Alan R. Stafford, Beverly A. Leslie, James C. Fredenburgh, David A. Weitz i Jeffrey I. Weitz. "Zinc promotes clot stability by accelerating clot formation and modifying fibrin structure". Thrombosis and Haemostasis 115, nr 03 (2016): 533–42. http://dx.doi.org/10.1160/th15-06-0462.
Pełny tekst źródłaMartinez, Marissa R., Adam Cuker, Angela M. Mills, Amanda Crichlow, Richard T. Lightfoot, Irina N. Chernysh, Chandrasekaran Nagaswami, John W. Weisel i Harry Ischiropoulos. "Enhanced lysis and accelerated establishment of viscoelastic properties of fibrin clots are associated with pulmonary embolism". American Journal of Physiology-Lung Cellular and Molecular Physiology 306, nr 5 (1.03.2014): L397—L404. http://dx.doi.org/10.1152/ajplung.00265.2013.
Pełny tekst źródłaJanmey, PA, JA Lamb, RM Ezzell, S. Hvidt i SE Lind. "Effects of actin filaments on fibrin clot structure and lysis". Blood 80, nr 4 (15.08.1992): 928–36. http://dx.doi.org/10.1182/blood.v80.4.928.928.
Pełny tekst źródłaJanmey, PA, JA Lamb, RM Ezzell, S. Hvidt i SE Lind. "Effects of actin filaments on fibrin clot structure and lysis". Blood 80, nr 4 (15.08.1992): 928–36. http://dx.doi.org/10.1182/blood.v80.4.928.bloodjournal804928.
Pełny tekst źródłaVarin, Remi, Shasultan Mirshahi, Pehzman Mirshahi, Li Lu-Hong, Gerald Kierzek, Jean-Francois Vigneau, Jean-Pierre Marie i in. "Improvement of Thrombolysis by Rivaroxaban, An Anti Xa Inhibitor. Potential Therapeutic Importance in Patients with Thrombosis". Blood 112, nr 11 (16.11.2008): 3031. http://dx.doi.org/10.1182/blood.v112.11.3031.3031.
Pełny tekst źródłaFaes, Camille, Anton Ilich, Erica M. Sparkenbaugh, Alisa S. Wolberg, Brian C. Cooley, Kenneth I. Ataga, Nigel S. Key i Rafal Pawlinski. "Alteration of the Structure and Dynamics of Venous Clot Formation in Human and Murine Sickle Cell Disease". Blood 128, nr 22 (2.12.2016): 2478. http://dx.doi.org/10.1182/blood.v128.22.2478.2478.
Pełny tekst źródłaBrown, Ashley C., Riley H. Hannan, Lucas H. Timmins, Janet D. Fernandez, Thomas H. Barker i Nina A. Guzzetta. "Fibrin Network Changes in Neonates after Cardiopulmonary Bypass". Anesthesiology 124, nr 5 (1.05.2016): 1021–31. http://dx.doi.org/10.1097/aln.0000000000001058.
Pełny tekst źródłaGao, Chunli, Bin Bao, Chunling Bao i Wenhui Wu. "Fungi Fibrinolytic Compound 1 Plays a Core Role in Modulating Fibrinolysis, Altering Plasma Clot Structure, and Promoting Susceptibility to Lysis". Pharmaceutics 15, nr 9 (14.09.2023): 2320. http://dx.doi.org/10.3390/pharmaceutics15092320.
Pełny tekst źródłaHantgan, Roy R., W. Gray Jerome i Marcie J. Hursting. "No Effect of Clot Age or Thrombolysis on Argatroban’s Inhibition of Thrombin". Blood 92, nr 6 (15.09.1998): 2064–74. http://dx.doi.org/10.1182/blood.v92.6.2064.
Pełny tekst źródłaHantgan, Roy R., W. Gray Jerome i Marcie J. Hursting. "No Effect of Clot Age or Thrombolysis on Argatroban’s Inhibition of Thrombin". Blood 92, nr 6 (15.09.1998): 2064–74. http://dx.doi.org/10.1182/blood.v92.6.2064.418k07_2064_2074.
Pełny tekst źródłaBaradet, T., J. W. Weisel i L. D. Peachey. "A study of fibrin clot structure under various ionic conditions using stereoscopic IVEM images". Proceedings, annual meeting, Electron Microscopy Society of America 49 (sierpień 1991): 194–95. http://dx.doi.org/10.1017/s0424820100085277.
Pełny tekst źródłaFlood, Veronica H., Chandrasekaran Nagaswami, Irina N. Chernysh, Hamid A. Al-Mondhiry, John W. Weisel i David H. Farrell. "Effects of Impaired Fibrinopeptide A Cleavage on Fibrin Clot Structure: Studies with an Aα R16C Dysfibrinogen." Blood 108, nr 11 (16.11.2006): 1617. http://dx.doi.org/10.1182/blood.v108.11.1617.1617.
Pełny tekst źródłaJerome, W. Gray, Stefan Handt i Roy R. Hantgan. "Endothelial Cells Organize Fibrin Clots into Structures That Are More Resistant to Lysis". Microscopy and Microanalysis 11, nr 3 (12.05.2005): 268–77. http://dx.doi.org/10.1017/s143192760505052x.
Pełny tekst źródłaChernysh, Irina N., Prashant K. Purohit, Chandrasekaran Nagaswami i John W. Weisel. "Remodeling of Clots without Proteolytic Digestion". Blood 118, nr 21 (18.11.2011): 1184. http://dx.doi.org/10.1182/blood.v118.21.1184.1184.
Pełny tekst źródłaGreenhalgh, Katie A., Mark W. Strachan, Saad Alzahrani, Paul D. Baxter, Kristina F. Standeven, Robert F. Storey, Robert A. S. Ariens, Peter J. Grant, Jackie F. Price i Ramzi A. Ajjan. "BβArg448Lys polymorphism is associated with altered fibrin clot structure and fibrinolysis in type 2 diabetes". Thrombosis and Haemostasis 117, nr 02 (2017): 295–302. http://dx.doi.org/10.1160/th16-07-0554.
Pełny tekst źródłaKonings, Joke, José W. P. Govers-Riemslag, Helen Philippou, Nicola J. Mutch, Julian I. Borissoff, Peter Allan, Sumitra Mohan, Guido Tans, Hugo ten Cate i Robert A. S. Ariëns. "Factor XIIa regulates the structure of the fibrin clot independently of thrombin generation through direct interaction with fibrin". Blood 118, nr 14 (6.10.2011): 3942–51. http://dx.doi.org/10.1182/blood-2011-03-339572.
Pełny tekst źródłade Vries, Judith J., Tamara Hoppenbrouwers, Cristina Martinez-Torres, Rezin Majied, Behiye Özcan, Mandy van Hoek, Frank W. G. Leebeek, Dingeman C. Rijken, Gijsje H. Koenderink i Moniek P. M. de Maat. "Effects of Diabetes Mellitus on Fibrin Clot Structure and Mechanics in a Model of Acute Neutrophil Extracellular Traps (NETs) Formation". International Journal of Molecular Sciences 21, nr 19 (26.09.2020): 7107. http://dx.doi.org/10.3390/ijms21197107.
Pełny tekst źródłaDe Vries, Judith Juliana, Chantal Visser, Lotte Geers, Johan A. Slotman, Henrik Endeman, Marieke J. H. A. Kruip, Moniek P. M. de Maat i The Dutch COVID & Thrombosis Coalition. "Does Fibrin Structure Contribute to the Increased Risk of Thrombosis in COVID-19 ICU Patients?" Blood 138, Supplement 1 (5.11.2021): 3208. http://dx.doi.org/10.1182/blood-2021-145307.
Pełny tekst źródłaXu, Shixin, Zhiliang Xu, Oleg V. Kim, Rustem I. Litvinov, John W. Weisel i Mark Alber. "Model predictions of deformation, embolization and permeability of partially obstructive blood clots under variable shear flow". Journal of The Royal Society Interface 14, nr 136 (listopad 2017): 20170441. http://dx.doi.org/10.1098/rsif.2017.0441.
Pełny tekst źródłaNeergaard-Petersen, Søs, Anne-Mette Hvas, Steen Kristensen, Erik Grove, Sanne Larsen, Fladia Phoenix, Zeyad Kurdee, Peter Grant i Ramzi Ajjan. "The influence of type 2 diabetes on fibrin clot properties in patients with coronary artery disease". Thrombosis and Haemostasis 112, nr 12 (2014): 1142–50. http://dx.doi.org/10.1160/th14-05-0468.
Pełny tekst źródłaJen, C. J., i L. V. McIntire. "Platelet Microtubules in Clot Structure Formation and Contractile Force Generation: Investigation of a Controversy". Thrombosis and Haemostasis 56, nr 01 (1986): 023–27. http://dx.doi.org/10.1055/s-0038-1661596.
Pełny tekst źródłaLeong, Lilley, Irina N. Chernysh, Yifan Xu, Cornell Mallari, Billy Wong, Derek Sim, Adam Cuker i in. "Hemophilia a Clots Generated with Recombinant Factor VIIa Differed in Structure and Composition from Those Formed with Factor VIII". Blood 128, nr 22 (2.12.2016): 3798. http://dx.doi.org/10.1182/blood.v128.22.3798.3798.
Pełny tekst źródłaTutwiler, Valerie, Alina D. Peshkova, Giang Le Minh, Sergei Zaitsev, Rustem I. Litvinov, Douglas B. Cines i John W. Weisel. "Fibrinolysis of Contracted Blood Clots Depends on Whether Plasminogen Activator Acts from inside or Outside". Blood 132, Supplement 1 (29.11.2018): 3773. http://dx.doi.org/10.1182/blood-2018-99-119659.
Pełny tekst źródłaWhyte, Claire S., Akriti Rastogi, Ellis Ferguson, Michela Donnarumma i Nicola J. Mutch. "The Efficacy of Fibrinogen Concentrates in Relation to Cryoprecipitate in Restoring Clot Integrity and Stability against Lysis". International Journal of Molecular Sciences 23, nr 6 (9.03.2022): 2944. http://dx.doi.org/10.3390/ijms23062944.
Pełny tekst źródłaUndas, Anetta, Krystyna Zawilska, Mariola Ciesla-Dul, Agata Lehmann-Kopydłowska, Agnieszka Skubiszak, Katarzyna Ciepłuch i Wiesława Tracz. "Altered fibrin clot structure/function in patients with idiopathic venous thromboembolism and in their relatives". Blood 114, nr 19 (5.11.2009): 4272–78. http://dx.doi.org/10.1182/blood-2009-05-222380.
Pełny tekst źródłaSidelmann, Johannes, Mikkel Brabrand, Robert Pedersen, Jørgen Pedersen, Kim Esbensen, Kristina Standeven, Robert Ariëns, Jørgen Gram i Jonas Sjøland. "Fibrin clot structure in patients with end-stage renal disease". Thrombosis and Haemostasis 98, nr 08 (2007): 339–45. http://dx.doi.org/10.1160/th06-12-0715.
Pełny tekst źródłaDavies, Nia Anne, Nicholas Kim Harrison, Roger H. Keith Morris, Simon Noble, Matthew James Lawrence, Lindsay Antonio D’Silva, Laura Broome i in. "Fractal dimension (df ) as a new structural biomarker of clot microstructure in different stages of lung cancer". Thrombosis and Haemostasis 114, nr 12 (2015): 1251–59. http://dx.doi.org/10.1160/th15-04-0357.
Pełny tekst źródłade Vries, Judith J., Charlotte J. M. Snoek, Dingeman C. Rijken i Moniek P. M. de Maat. "Effects of Post-Translational Modifications of Fibrinogen on Clot Formation, Clot Structure, and Fibrinolysis". Arteriosclerosis, Thrombosis, and Vascular Biology 40, nr 3 (marzec 2020): 554–69. http://dx.doi.org/10.1161/atvbaha.119.313626.
Pełny tekst źródłaGaule, Thembaninkosi G., i Ramzi A. Ajjan. "Fibrin(ogen) as a Therapeutic Target: Opportunities and Challenges". International Journal of Molecular Sciences 22, nr 13 (28.06.2021): 6916. http://dx.doi.org/10.3390/ijms22136916.
Pełny tekst źródłaWeisel, John W. "Multiple Approaches to Visualizing Fibrin Clot Structure and Assembly". Microscopy and Microanalysis 3, S2 (sierpień 1997): 329–30. http://dx.doi.org/10.1017/s1431927600008539.
Pełny tekst źródłaGantioqui, Jorell, Ivan Stevic, Paul Y. Kim, Keith K. Lau, Anthony K. C. Chan i Howard H. W. Chan. "The Architecture Of Fibrin Clots Formed From Plasma With Low Platelet Levels Are Less Altered In The Presence Of Factor-Specific Anticoagulants Compared With Unfractionated Heparin". Blood 122, nr 21 (15.11.2013): 578. http://dx.doi.org/10.1182/blood.v122.21.578.578.
Pełny tekst źródłaFaes, Camille, Anton Ilich, Amandine Sotiaux, Erica M. Sparkenbaugh, Michael W. Henderson, Laura Buczek, Joan D. Beckman i in. "Red blood cells modulate structure and dynamics of venous clot formation in sickle cell disease". Blood 133, nr 23 (6.06.2019): 2529–41. http://dx.doi.org/10.1182/blood.2019000424.
Pełny tekst źródłaVarin, Remi, Shahsultan Mirshahi, Pehzman Mirshahi, Jean Chidiac, Gerald Kierzek, Jean-Pierre Marie, Massoud Mirshahi, Claudine Soria i Jeannette Soria. "Effect of Rivaroxaban, An Oral Direct Factor Xa Inhibitor, On Whole Blood Clot Permeation and Thrombolysis: Critical Role of Red Blood Cells." Blood 114, nr 22 (20.11.2009): 1064. http://dx.doi.org/10.1182/blood.v114.22.1064.1064.
Pełny tekst źródłaUndas, Anetta. "Fibrin clot properties and their modulation in thrombotic disorders". Thrombosis and Haemostasis 112, nr 07 (2014): 32–42. http://dx.doi.org/10.1160/th14-01-0032.
Pełny tekst źródłaDargaud, Yesim, Jean C. Bordet, Chantal Huchon i Claude Negrier. "How can We Predict Efficacy of rFVIIa in Hemophilia Patients with Inhibitors?" Blood 114, nr 22 (20.11.2009): 3487. http://dx.doi.org/10.1182/blood.v114.22.3487.3487.
Pełny tekst źródłaWeisel, John W., Tatiana Lebedeva, Chandrasekaran Nagaswami, Vincent M. Hayes, Walter Massefski, Rustem I. Litvinov, Lubica Rauova, Thomas J. Lowery i Douglas B. Cines. "Polyhedrocytes: Compressed Polyhedral Erythrocytes In Contracted Blood Clots and Thrombi". Blood 122, nr 21 (15.11.2013): 452. http://dx.doi.org/10.1182/blood.v122.21.452.452.
Pełny tekst źródłaAjjan, Ramzi, Bernard C. B. Lim, Kristina F. Standeven, Robert Harrand, Sarah Dolling, Fladia Phoenix, Richard Greaves i in. "Common variation in the C-terminal region of the fibrinogen β-chain: effects on fibrin structure, fibrinolysis and clot rigidity". Blood 111, nr 2 (15.01.2008): 643–50. http://dx.doi.org/10.1182/blood-2007-05-091231.
Pełny tekst źródłaLandi, Elia, Marco Mugnaini, Tunahan Vatansever, Ada Fort, Valerio Vignoli, Elvira Giurranna, Flavia Rita Argento i in. "Advancing Thrombosis Research: A Novel Device for Measuring Clot Permeability". Sensors 24, nr 12 (9.06.2024): 3764. http://dx.doi.org/10.3390/s24123764.
Pełny tekst źródłaZąbczyk, Michał, Joanna Natorska i Anetta Undas. "Factor XIII and Fibrin Clot Properties in Acute Venous Thromboembolism". International Journal of Molecular Sciences 22, nr 4 (5.02.2021): 1607. http://dx.doi.org/10.3390/ijms22041607.
Pełny tekst źródłaBowley, Sheryl R., i Susan T. Lord. "Fibrinogen variant BβD432A has normal polymerization but does not bind knob “B”". Blood 113, nr 18 (30.04.2009): 4425–30. http://dx.doi.org/10.1182/blood-2008-09-178178.
Pełny tekst źródłaPan, Xiaoxi, Yun Gong, Ya Xu, Robert Ariens i Michael Routledge. "Urban Particulate Matter Induces Changes in Gene Expression in Vascular Endothelial Cells that Are Associated with Altered Clot Structure In Vitro". Thrombosis and Haemostasis 118, nr 02 (2018): 266–78. http://dx.doi.org/10.1160/th17-05-0362.
Pełny tekst źródłaMoiseiwitsch, Nina, Kimberly A. Nellenbach, Nina A. Guzzetta, Ashley C. Brown i Laura Downey. "Ex Vivo and In Vivo Evaluation of Fibrinogen Concentrate to Mitigate Post-Surgical Bleeding in Neonates". Blood 138, Supplement 1 (5.11.2021): 1034. http://dx.doi.org/10.1182/blood-2021-153823.
Pełny tekst źródłaCollet, Jean-Philippe, Jennifer L. Moen, Yuri I. Veklich, Oleg V. Gorkun, Susan T. Lord, Gilles Montalescot i John W. Weisel. "The αC domains of fibrinogen affect the structure of the fibrin clot, its physical properties, and its susceptibility to fibrinolysis". Blood 106, nr 12 (1.12.2005): 3824–30. http://dx.doi.org/10.1182/blood-2005-05-2150.
Pełny tekst źródła